Altimmune, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Gaithersburg, MD
SEC filing record 1 source field available
Fiscal year end
31 December
Altimmune, Inc. has filed 1,446 SEC EDGAR filings since 06 May 2005

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page
25
Current page
40
4

4 filing

Filing date
27 May 2011
Reporting date
25 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 May 2011
Reporting date
17 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 May 2011
Reporting date
17 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 May 2011
Reporting date
23 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32587

8-K filing

Filing date
12 May 2011
Reporting date
11 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-32587

10-Q filing

Filing date
11 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-32587

10-K/A filing

Filing date
29 Apr 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-32587

10-K filing

Filing date
31 Mar 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32587

8-K filing

Filing date
28 Mar 2011
Reporting date
28 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80900

SC 13G/A

Filing date
14 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-80900

SC 13G filing

Filing date
31 Jan 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-80900

SC 13G filing

Filing date
31 Jan 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jan 2011
Reporting date
21 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jan 2011
Reporting date
21 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jan 2011
Reporting date
21 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80900

PHARMATHENE, INC.

Filing date
18 Jan 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32587

8-K filing

Filing date
30 Dec 2010
Reporting date
23 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Dec 2010
Reporting date
23 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-80900

SC 13D/A

Filing date
27 Dec 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Dec 2010
Reporting date
13 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32587

8-K filing

Filing date
14 Dec 2010
Reporting date
08 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Dec 2010
Reporting date
08 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Dec 2010
Reporting date
08 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Dec 2010
Reporting date
08 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Dec 2010
Reporting date
08 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .